Avricore Health (AVCRF) Capital Expenditures (2009 - 2026)

Avricore Health (AVCRF) has reported Capital Expenditures for 13 consecutive years, with -$2075.3 the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures rose 95.54% year-over-year to -$2075.3; the TTM figure through Mar 2026 stood at -$17781.1 (up 94.31% YoY), while the FY2025 annual figure was -$63339.2, up 52.11% from the prior year.
• Capital Expenditures improved to -$2075.3 in Q1 2026 per AVCRF's latest filing, from -$2979.5 in the prior quarter.
• Across five years, Capital Expenditures topped out at $1.4 million in Q4 2022 and bottomed at -$465996.9 in Q3 2022.
• Historically, Capital Expenditures has averaged -$7902.2 across 5 years, with a median of -$68339.7 in 2024.
• On a YoY basis, Capital Expenditures climbed as much as 789.45% in 2022 and fell as far as 926.92% in 2022.
• Avricore Health's Capital Expenditures stood at $1.4 million in 2022, then slumped by 117.49% to -$252185.1 in 2023, then jumped by 48.75% to -$129250.7 in 2024, then jumped by 97.69% to -$2979.5 in 2025, then soared by 30.35% to -$2075.3 in 2026.
• Business Quant data shows AVCRF's Capital Expenditures at -$2075.3 in Q1 2026, -$2979.5 in Q4 2025, and -$11451.0 in Q3 2025.